An outside the united states customer observed falsely depressed creatinine_2 (crea_2) results on six patient samples on an atellica ch analyser, lot 221736.The erroneous results were reported to the physician(s).The results were not questioned by the physician(s).The samples were reprocessed on an original instrument.The repeat results were higher than the initial results.The repeat results were considered as correct results by the physician(s).Quality controls (qc) were in range at the time of the event.The interpretation of results section of the atellica ch crea_2 instructions for use (ifu) states: "results of this assay should always be interpreted in conjunction with patient's medical history, clinical presentation and other findings.".Siemens healthcare diagnostics is investigating.
|
Siemens filed the initial mdr 1219913-2023-00086 on apr 13, 2023.Additional information: apr 21, 2023 and may 04, 2023: the customer observed falsely depressed creatinine_2 (crea_2) results on six patient samples on an atellica ch analyser, lot 221736.The erroneous results were reported to the physician(s).The results were not questioned by the physician(s).The samples were reprocessed on the original instrument.The repeat results were higher than the initial results.The repeat results were considered as correct results by the physician(s).The customer provided the gender of all patient samples.Sample ids gender (b)(6) male (b)(6) male (b)(6) female (b)(6) female (b)(6) male (b)(6) female siemens was unable to obtain information to determine if there is an indication of reagent delivery, or if there is evidence that a foaming issue occurred without photometer or result monitor data.No maintenance information was available for atellica cm01751.Siemens was unable to query atellica cm01751 for process errors posted on (b)(6) 2023.The initial issue was reported as discordant (low) atellica creatinine_2 (crea_2) results.Siemens cannot definitively determine the cause of this discrepant result.Contributing factors such as sample integrity, preanalytical variables cannot be ruled out.Quality control was in range and no issues were noted with other patient samples indicating that the instrument and reagents were performing acceptably.Repeat of the same sample yielded expected results.Based on the results of the investigation, return of the patient sample is not warranted.A potential product issue has not been identified.Customer instrument is fully functional.In section h6, the investigation finding, and investigation conclusion codes were updated.
|